Clinical Trial Update: Impact of Dapagliflozin in Anemic Chronic Kidney Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dapagliflozin in patients with chronic kidney disease and anemia; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Mansoura University | Conditions: Chronic Kidney Disease(CKD), Anemia, Kidney Disease, Chronic | Phase 2 | Status: RECRUITING